Vistra Corp. reports Q1 2026 results on May 7 with short sellers quietly adding exposure even as the stock trades well below analyst targets — a divergence that frames the debate heading into the print.
The most notable shift in positioning is the sharp rise in short interest over the past month. Short positions have climbed 29% over the past 30 days to 3.4% of the free float — a meaningful build, though not extreme in absolute terms. The jump was concentrated in late April, when shares short jumped from roughly 9.1 million to nearly 12 million in the space of a few sessions around April 24. Borrowing costs remain negligible at 0.36% and borrow availability is extremely loose, meaning new short positions face no supply constraint. Options traders, meanwhile, are running only marginally defensive — the put/call ratio is 1.44, actually a touch below its 20-day average of 1.48, and well off the 52-week high of 1.72. The message from the options market is one of relative calm heading into earnings, not hedging urgency.
The bull-bear divide centres on execution quality and whether Vistra can convert a strong EBITDA growth story into durable free cash flow. Bulls point to the Cogentrix acquisition lifting EBITDA forecasts by roughly 7%, a free cash flow conversion target at or above 60% of adjusted EBITDA from 2026, and expanded retail margins backed by effective hedging. The stock has gained 6% over the past month to $160.38 — a decent recovery — but it remains roughly 30% below its peak, which bears cite as evidence that investors are sceptical about the trajectory. Commodity price volatility has already inflicted an estimated $1.6 billion adverse hit to adjusted EBITDA, and bears argue the leverage reduction path may be too optimistic given capacity and market risks. The Street remains broadly constructive — 14 buy ratings, a mean target near $228 — but TD Cowen and JPMorgan both trimmed targets in the past week, with JPMorgan cutting from $240 to $231 while keeping Overweight. The direction of travel from analysts is positive ratings paired with lower price ambitions.
The two most recent earnings prints offer context worth noting. After the February 27 report, the stock fell 6.1% on the day and extended those losses to a 10.3% decline over the following five sessions. The February 26 event produced a smaller 0.8% drop on the day. Both prints drew negative reactions, suggesting the market has demanded more from results than management has delivered.
The Q1 print is therefore less a test of whether Vistra's power generation thesis is intact and more about whether free cash flow conversion has actually improved — and whether the Cogentrix addition is translating into the numbers rather than just the forecast.
See the live data behind this article on ORTEX.
Open VST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
